Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04469933
Other study ID # 2020-03ObsCHRMT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2016
Est. completion date May 1, 2018

Study information

Verified date June 2020
Source Centre Hospitalier Régional Metz-Thionville
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Aim: Identify predictive factors of good results after primary Descemet's Membrane Endothelial Keratoplasty (DMEK) in Fuchs Endothelial Corneal Dystrophy (FECD).

82 patients (102 eyes) with Fuchs Endothelial Corneal Dystrophy (FECD) underwent DMEK between March 2016 and March 2018 were analyzed. Follow-up time was 12 months. The studied prognostic criteria were: pre-operative Central Corneal Thickness (CCT), CCT's delta between pre and D15 post-operatively, anterior mean keratometry, pre-operative endothelial cell density (ECD) and postoperative ECD at 6 and 12 months, pre-operative visual acuity, donors' and recipients' ages, recipients' sex, rebubbling and triple procedure (DMEK combined with cataract surgery).


Description:

Aim: Identify predictive factors of good results after primary Descemet's Membrane Endothelial Keratoplasty (DMEK) in Fuchs Endothelial Corneal Dystrophy (FECD).

A monocentric retrospective observational study was realized at the Regional Hospital Center of Metz-Thionville, Mercy Hospital, Metz, France.

102 eyes of 82 patients with Fuchs Endothelial Corneal Dystrophy (FECD) underwent DMEK between March 2016 and March 2018 were analyzed. Follow-up time was 12 months. The studied prognostic criteria were: pre-operative Central Corneal Thickness (CCT), CCT's delta between pre and D15 post-operatively, anterior mean keratometry, pre-operative endothelial cell density (ECD) and postoperative ECD at 6 and 12 months, pre-operative visual acuity, donors' and recipients' ages, recipients' sex, rebubbling and triple procedure (DMEK combined with cataract surgery). Surgery was considered successful when best spectacle corrected visual acuity (BSCVA) was 0.1 logMar or less (≥0.8) 1 year postoperatively.


Recruitment information / eligibility

Status Completed
Enrollment 102
Est. completion date May 1, 2018
Est. primary completion date May 1, 2018
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Over 18,

- had advanced FECD associated with visual symptoms and reduced visual acuity .

Exclusion Criteria:

- Prior intraocular surgery other than cataract

- Other indications for DMEK surgeries than FECD,

- Eyes with corneal (except FECD), retinal or optic nerve diseases

- Per-operative difficulties (tear's graft or complicated unfolding graft)

- Primary graft failure (cornea that failed to clear in the presence of an attached graft)

- Secondary graft failure (corneal decompensation after an initial period of a functional graft)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Régional Metz-Thionville

Outcome

Type Measure Description Time frame Safety issue
Primary Pre-operative Central Corneal Thickness (CCT), Pre-operative CCT (µm) measured by an anterior segment optical coherence tomography (AS-OCT; RS-3000; Nidek Co. Ltd, Japan) day 1
Primary Post-operative Central Corneal Thickness (CCT), Post-operative CCT (µm) measured by an anterior segment optical coherence tomography (AS-OCT; RS-3000; Nidek Co. Ltd, Japan) Months 12
Primary CCT's delta CCT's delta (µm) between pre and D15 post-operatively day 15
Secondary anterior mean keratometry anterior mean keratometry (calculated by an auto keratometer Visionix Luneau L67, France) day 1
Secondary pre-operative endothelial cell density ECD pre-operative ECD (using a non-contact specular microscope CEM-530; Nidek Co. Ltd, Japan) day1
Secondary post-operative endothelial cell density (ECD) post-operative ECD at 6 months (using a non-contact specular microscope CEM-530; Nidek Co. Ltd, Japan) 6 months
Secondary post-operative endothelial cell density (ECD) post-operative ECD at 12 months (using a non-contact specular microscope CEM-530; Nidek Co. Ltd, Japan) 12 months
Secondary pre-operative Visual Acuity pre-operative Visual Acuity (using Monoyer chart and converted it to logMar scale) day 1
Secondary donors' and recipients' ages donors' and recipients' ages day 1
Secondary recipients' sex recipients' sex day 1
Secondary rate of rebubbling the rate of rebubbling %(postoperative graft detachment) months 6
See also
  Status Clinical Trial Phase
Recruiting NCT06101017 - Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
Completed NCT03763721 - The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation N/A